Thanks mate. I'm super short on time today - so this is not a definitive answer. The last Corporatepresentation back in Sept showed the MAST trial of CF33 running at 3 x 108 - which is 300 million PFU. That's 300 x larger than the max dose in the Checkvacc trial. However - I think they have since progressed to 109 (1 billion PFU) but I can't find a source for that. At 1 billion PFU they'd be delivering 1000x the Checkvacc max dose. It was certainly Yuman's intention to go that high.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)